Megan Brandt

Sr. VP of Clinical & Regulatory Affairs

Megan joined Metavention in September 2018 bringing more than 15 years of medical device leadership to the organization with a proven track record for securing multiple FDA and international regulatory approvals for novel, innovative technologies. Most recently, Megan was Sr. Vice President, Medical Affairs & Healthcare Policy at CHF Solutions, where she led functional teams in Regulatory, Clinical, Reimbursement, Quality and Operations. Prior to CHF Solutions, Ms. Brandt served as Vice President, Quality & Regulatory Affairs at Cardiovascular Systems (CSI). Megan earned her B.S. in biochemistry and microbiology from Minnesota State University-Mankato.